Association of sulfonylureas with the risk of dementia: A population‐based cohort study.

Background: Sulfonylureas are oral glucose‐lowering medications positioned as a second‐line therapy for type 2 diabetes. Evidence relating them to cognitive decline has been mixed. The objective was to determine whether sulfonylurea use was associated with a differential risk of dementia compared wi...

Descripción completa

Detalles Bibliográficos
Publicado en:	Journal of the American Geriatrics Society Vol. 71; no. 10; pp. 3059 - 3071
Autores principales:	Wu, Che‐Yuan, Iskander, Carina, Wang, Christa, Xiong, Lisa Y., Shah, Baiju R., Edwards, Jodi D., Kapral, Moira K., Herrmann, Nathan, Lanctôt, Krista L., Masellis, Mario, Swartz, Richard H., Cogo‐Moreira, Hugo, MacIntosh, Bradley J., Rabin, Jennifer S., Black, Sandra E., Saskin, Refik, Swardfager, Walter
Formato:	Artículo
Publicado:	Wiley-Blackwell Oct2023
Materias:	Public health surveillance Retrospective studies Dementia risk factors Alzheimer's disease Confidence intervals Insulin secretagogues Hypoglycemic agents Risk assessment Type 2 diabetes Comparative studies Descriptive statistics Research funding Odds ratio Longitudinal method Enzyme inhibitors Algorithms Proportional hazards models Disease complications
Acceso en línea:	Ver este registro en EBSCOhost

Internet

Ver este registro en EBSCOhost